For the 7th time, PharmaLab, picks up the latest developments in regulations, quality control and assurance and in laboratory methods and systems.
For the 7th time already, PharmaLab, the leading European congress on analytics, bioanalytics and microbiology in the pharmaceutical laboratory, picks up the latest developments in regulations, quality control and assurance and in laboratory methods and systems. Last year, more than 300 experts from 25 countries met there for an experience and information exchange. This year, more than 70 speakers will report in five parallel conference tracks and in a pre-conference workshop about the latest developments in analytics, bioanalytics and microbiology and about their experiences in laboratory operations. The increasing importance of complex biological drugs, new adopted guidelines, but also political and social changes such as Brexit or the EU initiative to reduce animal testing bring about many changes. Pharmalab deals with these changes – not matter whether regulatory, scientific or technical nature.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
Analytics and Bioanalytics:
ICH Guidelines
In the field of analytics, there is a whole range of topics that currently keep experts busy. These are, on the one hand, the changes that have taken place or are pending in the area of Analytical Procedure Development and Validation of Analytical Procedures, i.e. the ICH Guidelines Q14 and Q2(R1), and subsequently the topic of Analytical Procedure Life Cycle Management (APLM).
The current ICH Q2(R1) “Guideline on Validation of Analytical Procedures: Text and Methodology” does not address modern analytical methods (such as Near Infrared (NIR) or Raman spectroscopy). The lack of guidance for these analytical methods can lead to regulatory applications with insufficient validation data for such analytical methods. This is especially the case for methods that depend on multivariate statistical models that are specifically designed for the analysis of peak-shaped data (e.g. NIR or Raman spectroscopy). For these models there is currently no ICH Validation Guideline available. However, NIR and Raman are often used in in-process controls and Real Time Release Testing (RTRT). According to ICH, the revision of ICH Q2(R1) will therefore deal with the validation of modern analytical methods. The revision process will also consider statistical aspects in validation together with possible validation parameters for methods such as NIR, NMR and couplings such as CE-MS, CE-ICP-MS, LC-NMR, GC-MS, LC-MS.
There is currently no ICH Guideline on Analytical Procedure Development. Therefore, applicants often submit analytical validation results alone and rarely present a performance assessment of the method supported by analytical development results. This complicates regulatory assessment – especially when modern analytical methods are used (e.g. RTRT and multivariate methods for process control). Furthermore, the lack of guidelines impede the applicant’s ability to present a scientific basis based on modern approaches such as Quality by Design (QbD) for more flexible post-approval analytical method changes.
Following the considerations of the ICH, the new Q14 Analytical Procedure Development Guideline is supposed to harmonize the scientific approaches to analytical method development and to provide the principles related to the description of the analytical development process. It is also supposed to improve the communication between industry and authorities and to enable an efficient, scientific and risk-based approval and post-approval change management process for analytical procedures.
Over the two days of PharmaLab 2019, current developments in this area will be presented and highlighted. Experts from the ECA expert groups and the authorities will present the content of the guidelines and draft guidelines and discuss the consequences for analytical quality control with the participants.
But other guidelines are also currently under discussion or will be updated. Among them are ICH M10: Draft Guideline on bioanalytical method validation published for public comment or the consultation of the MHRA on their plans to apply the principles of analytical quality through design (AQbD) to its pharmacopoeia – including the Analytical Target Profile (ATP).
Cell-based, tissue products and ATMP:
There is hardly any other field in which development is as rapid as in Advanced Therapy Medicinal Products (ATMPs). Everything started at the end of 2017 with the publication of the new GMP for ATMP Guidelines. Subsequently, various documents and drafts for guidelines were published, which currently or in the future will regulate the development and approval of such novel therapies – but are also intended to promote them. Examples would be the “Draft Guidelines on Good Clinical Practice for Advanced Therapy Medicinal Products” or the “Draft Guideline on Safety and Efficacy Follow-up and Risk Management of ATMPs”.
This group of modern therapies and products is characterized by a high degree of heterogeneity and complexity of the individual products. In addition, there are often special conditions such as the open manipulation of cells and tissues. These conditions may be necessary for the production of such products on a medical-surgical level, or due to the short shelf life of the end product obtained. This also poses new challenges for the analytical and microbiological testing of such products. New procedures and systems are sometimes unavoidable to obtain meaningful results in the shortest possible time. Rapid testing and analysis is a challenge for products with short shelf lives. So, new methods have to meet requirements such as
Comparability with existing compendial methods
Appropriate sensitivity and robustness
Suitability testing and validation
Low variability
The PharmaLab congress tracks for cells, tissues, cell- and tissue-based products and ATMPs, for Rapid Microbiological Methods as well as the Mycoplasma Workshop will cover entirely or at least partly microbiological and analytical quality requirements, suitable methods and test systems and their application. Representatives from authorities and colleagues from small and industrial manufacturing will explain the current requirements and report on their experiences with inspections and implementations in the company.
Microbiology:
Endotoxins and pyrogens
Moreover, in the field of microbiological control of medicinal products, medical devices and in environmental and personnel monitoring, regulatory and scientific/technical innovations require the attention of companies and experts.
The testing of endotoxins and pyrogens continues to be an “explosive” topic.
In the field of testing bacterial endotoxins, testing with recombinant test systems is available in addition to testing with the classic lysate of horseshoe crabs (LAL). This alternative – which is linked with the European initiatives to reduce tests and trials involving animals – lead to the publication of the European Pharmacopoeia (Ph. Eur.) new chapter – 2.6.32. Test for bacterial endotoxins with recombinant factor C (rFC) for comment. This is not really a new topic in the European Pharmacopoeia. The EP was one of the first pharmacopoeias to refer to rFC – in Chapter 5.1.10 entitled Guidelines for the use of the test for bacterial endotoxins in Supplement 8.8 (2016). It already describes that the recombinant protein can be used as an alternative to Limulus amebocyte lysate. Now, with a chapter of its own, the Ph.Eur. goes one step further. This is also important, because LAL currently depends on a single lysate source, the horseshoe crab family, and in particular on two crabs, Limulus polyphämus and Tachypleus tridentatus, both known to be at risk. The new chapter describes a test, which is based on a recombinant factor C and a fluorimetric endpoint detection method. It is based on a gene sequence of horseshoe crabs. Chapter 2.6.32. initially describes only the fluorimetric method, as the rFC kits currently available on the European market and most available scientific data are based on this method.
In the area of alternative pyrogen testing, the MAT is becoming increasingly important, especially as the approval to carry out the classical rabbit test is only granted to a limited extent today. However, the global acceptance of MAT still leaves much to be desired. This may be due to the diversity of the methods, but also to the lack of more detailed descriptions of cell numbers, volume rations, diluents or vortexing (force and time), as these are all relevant for a successful MAT application.
The two-day PharmaLab track on endotoxin and pyrogen testing will therefore cover current topics such as
International regulatory developments
Feasibility of new and innovative products and processes
Special topics like masking / LER
Testing of critical substances
Application of alternative test methods – MAT or RFC
Experts from all over the world, even from Japan and the Chinese authorities are expected as speakers.
Monitoring and rapid methods
Microbiological rapid methods, as already mentioned above, are also gaining in importance as the relevance of complex biotechnological drugs increases. The safety of such new therapies, products and active substances is of enormous importance. An important topic in the focus of risk assessment and safety assessment is contamination with microorganisms and mycoplasmas as well as their detection, prevention and control. The PharmaLab congress tracks on Microbiological Rapid Methods and the Mycoplasma Workshop provide an opportunity to learn and discuss the latest advances in the field of the latest technological developments as well as practical aspects and concerns in meeting regulatory requirements.
But not only the area of product testing is affected by technological changes. Microbiological environmental monitoring is also currently undergoing change. Systems for real-time or online measurement of air, water or surface microbial counts are increasingly pushing their way into the market. They offer the possibility to react quickly and immediately to deviations and to obtain the necessary information quickly from monitoring even for products with short release times. However, these new systems also bring with them features that currently make implementation even more complex:
Proof of comparability with conventional methods
The improved sensitivity and thus increase of the detectable bacterial counts (conflict with existing limits)
The difficulty of subsequent cultivation for germ determination
The differentiation between living and dead cells
PharmaLab will provide an overview of the current requirements, the available systems and methods and their areas of application in a one-day session. Speakers from industry, laboratory and industry will report on their experiences and the challenges involved in introducing, establishing and validating real-time testing systems.
Exhibition
In addition to the lectures and discussion opportunities, e.g. during the social event on the first evening, PharmaLab also offers an accompanying exhibition at which participants can get an update on the latest products and services in analytics, bioanalytics and microbiology.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.